Oncolytics Biotech Inc. (ONCY) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -10.17M | -6.26M | -6.65M | -5.47M | -6.5M | -7.85M | -4.83M | -6.82M | -7.47M | -6.12M | -6.03M | -8.46M | -7.83M | -5.94M | -4.25M | -6.92M | -6.25M | -6.34M | -3.73M | -6.8M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -56.52% | 20.17% | -37.64% | 19.77% | 13% | -28.12% | 19.87% | 19.44% | 4.6% | -3.12% | -41.98% | -22.38% | -25.22% | 6.27% | -13.77% | -1.77% | -12.28% | -10.54% | 39.03% | -8.6% |
| Net Income | -12.89M | -1.51M | -14.4M | -6.17M | -6.69M | -8.02M | -9.54M | -7.26M | -6.89M | -3.95M | -9.93M | -7.44M | -6.44M | -8.55M | -4.41M | -5.09M | -6.78M | -7.75M | -4.87M | -7.25M |
| Depreciation & Amortization | 22.31K | 0 | 93K | 94K | 97K | 98K | 105K | 98K | 123K | 107K | 103K | 96K | 97K | 99.01K | 97.82K | 97.61K | 98K | 96.97K | 84.52K | 163.83K |
| Stock-Based Compensation | 3.21M | 0 | 4.12M | 523K | 1.21M | 1.2M | 445K | 506K | 576K | 759K | 750K | 242K | 317K | 748.98K | 500K | 490.11K | 639K | 1.13M | 1.01M | 1.03M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -707K | 444K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.14M | -5.29M | 950K | 293K | -262K | -163K | -155K | -382K | -1.24M | -4.57M | 74K | 75K | -251K | -71.66K | -1.25M | -802.81K | 447K | 322.11K | -1.18M | 658.05K |
| Working Capital Changes | -1.65M | 537.73K | 2.59M | -216K | -854K | -960K | 4.32M | 215K | -33K | 1.53M | 3.67M | -1.88M | -1.55M | 1.84M | 815.52K | -1.61M | -657K | -132.17K | 1.23M | -1.4M |
| Change in Receivables | -541.09K | -7.15K | 18K | 17K | -21K | 0 | 1.47K | -1.47M | -87K | 615K | -71K | 171K | -209K | -24.2K | -141.25K | -253.39K | 764K | -614.74K | -115.46K | -24.19K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -8.37K | -936 | -7K | 0 | 0 | -6K | -32K | -155K | -46K | -3K | 6.77M | 6.79M | 6.67M | -20.35M | -8.57K | -11.64K | -36K | -74.71K | -204.64K | -6.6K |
| Capital Expenditures | -8.37K | -936 | -7K | 0 | 0 | -6K | -32K | -155K | -46K | -3K | 0 | 0 | -5K | 740 | -8.57K | -11.64K | -36K | -74.71K | -204.64K | -6.6K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.77K | 6.79K | 6.67K | -20.35K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 10.62M | 2.61M | 4.14M | 5.37M | 5.89M | 3.34M | -173K | 1.98M | 1.5M | 1.74M | 21.29M | 3.69M | 5.27M | 5.87M | 1.16M | 156.27K | 5.01M | -51.71K | -79.67K | 7.98M |
| Debt Issued (Net) | 0 | 0 | -101K | -102K | -103K | -100K | -80K | -65K | -103K | -104K | -102K | -100K | -101K | -101.59K | -96K | -93.67K | -89K | -80.01K | -75.27K | -98.56K |
| Equity Issued (Net) | 10.62M | 5.02M | 4.24M | 5.47M | 5.99M | 3.44M | -158K | 2.04M | 1.6M | 1.47M | 21.33M | 3.45M | 5.37M | 5.97M | 1.26M | 249.94K | 5.09M | -9.2K | -9.23K | 8.07M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.23K | 0 |
| Other Financing | 0 | -2.41M | 0 | 0 | 0 | 0 | 65K | 0 | 0 | 375K | 63K | 343K | 0 | -242 | 0 | 0 | 12K | 37.5K | 4.83K | 6.77K |
| Net Change in Cash | 405.82K | -3.67M | -2.27M | -677K | -639K | -3.66M | -5.25M | -4.75M | -5.31M | -5.07M | 22.46M | 1.65M | 4.21M | -20.7M | -1.33M | -5.79M | -1.78M | -6.83M | -2.71M | 437.27K |
| Free Cash Flow | -10.17M | -6.26M | -6.66M | -5.47M | -6.5M | -7.85M | -4.86M | -6.97M | -7.51M | -6.13M | -6.03M | -8.46M | -7.83M | -5.94M | -4.26M | -6.93M | -6.29M | -6.41M | -3.94M | -6.8M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -56.52% | 20.22% | -36.88% | 21.55% | 13.53% | -28.15% | 19.34% | 17.61% | 4.07% | -3.19% | -41.69% | -22.17% | -24.59% | 7.37% | -8.08% | -1.84% | -12.92% | -11.85% | 35.86% | -8.65% |
| FCF per Share | -0.09 | -0.07 | -0.07 | -0.06 | -0.08 | -0.10 | -0.06 | -0.09 | -0.10 | -0.08 | -0.09 | -0.13 | -0.13 | -0.10 | -0.07 | -0.12 | -0.11 | -0.12 | -0.07 | -0.13 |
| FCF Conversion (FCF/Net Income) | 0.79x | 4.16x | 0.46x | 0.89x | 0.97x | 0.98x | 0.51x | 1.29x | 1.08x | 1.55x | 0.81x | 1.53x | 1.65x | 0.94x | 1.26x | 1.73x | 1.17x | 1.03x | 0.97x | 1.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27K | 7K | 0 | 0 | 0 | 2K | 0 | 0 | 5.16K | 12.71K | 0 |